Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-86.34	184.76	1352.76
Graham Fair Price	41.94	0.31	0.22
PEG	-82.40	1.38	7.86
Price/Book	6.64	5.21	4.88
Price/Cash Flow	45.78	-1019.81	-1880.84
Prices/Earnings	-46.68	134.04	251.38
Price/Sales	-46.68	5.41	10.15
Price/FCF	45.78	-1019.81	-1880.84
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.20	0.20
Operating Margin	-16.65	< 0.005	< 0.005
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	63.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.47	-0.23	107.91
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.41	2.67	89.10
EPS QOQ	0.32	0.97	203.03
FCF QOQ	0.99	-0.97	-2.22
Revenue QOQ	-0.59	1.00	69.58
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.24	7.62	-50.00
Days Sales Outstanding (DSO)	186.42	93.45	-49.87
Inventory Turnover	5.90	11.81	100.00
Debt/Capitalization	0.04	0.06	44.44
Quick Ratio	1.79	2.02	12.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.67	0.67	0.37
Cash	0.19	0.29	57.85
Capex	< 0.005	< 0.005	-111.92
Free Cash Flow	< 0.005	< 0.005	-97.40
Revenue	0.32	0.65	100.74
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.13	2.11	-0.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-11.36	-6.54	42.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating